Thyrocare Technologies Ltd - 539871 - Announcement Under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation13-04-2023
13-04-2023
Healthcare stock is trading at a discount of 50% from 52-week-high, Board declares 18 per share dividend
With a market valuation of 2,365 Cr, Thyrocare Technologies is a small-cap company with operations in the healthcare industry.08-04-2023
Thyrocare Technologies Ltd - 539871 - Corporate Action-Board approves Dividend
Corporate Action-for declaration of interim dividend for FY 2022-23.07-04-2023
Thyrocare Technologies Ltd - 539871 - Board Meeting Outcome for Declaration Of Interim Dividend For The FY 2022-23.
In continuation to our letter dated April 1, 2023 and in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company, at their meeting held on today, April 7, 2023, inter allia, have declared an interim dividend at the rate of INR 18/- (Rupees Eighteen only per share), (180% of the face value of INR 10/- each) for the financial year 2022-23. The Board has fixed, Thursday April 20, 2023 as the record date for the purpose of determining the entitlement of shareholders for the interim dividend07-04-2023
Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Board Meeting Intimation For Declaration Of Interim Dividend, If Approved By The Board
Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/04/2023 ,inter alia, to consider and approve Board Meeting Intimation for declaration of interim dividend, if Approved by the Board01-04-2023
Thyrocare Technologies Ltd - 539871 - Closure Of Trading Window
Intimation of closure of trading window under the provisions of SEBI (Prohibition of Insider Trading) Regulations, 201531-03-2023
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with Investors/Analysts13-03-2023
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd10-03-2023
Thyrocare Technologies Ltd - 539871 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 10, 2023 for Docon Technologies Pvt Ltd & API Holdings Ltd10-03-2023